Indian Drug Firm Gets Notice After Oxford Covid Vaccine Trial Paused

The central drug regulator has issued notice to Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine candidate for...